SEC 13F Intelligence

Artia Global Partners LP / ISI

Artia Global Partners LP’s Ionis Pharmaceuticals Inc Position

Does Artia Global Partners LP own Ionis Pharmaceuticals Inc (ISI)? Yes — 144.4K shares worth $11M (+2.17% of its 13F portfolio) as of Q1 2026.

Position Value
$11M
Q1 2026
Shares
144.4K
% of Portfolio
+2.17%
Quarters Held
5
currently held

Position History ISI

Reported value by quarter
Q2 ’24: $3MQ2 ’24Q3 ’24: $1MQ3 ’24Q3 ’25: $4MQ3 ’25Q4 ’25: $11MQ4 ’25Q1 ’26: $11MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026144.4K$11M+2.17%
Q4 2025144.4K$11M+1.62%
Q3 202560.2K$4M+0.62%
Q3 202430.5K$1M+0.33%
Q2 202462.5K$3M+0.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of ISI.